Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
Titel:
Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
Auteur:
Conlon, Neil T Roche, Sandra Mahdi, Amira F Browne, Alacoque Breen, Laura Gaubatz, Johanna Meiller, Justine O'Neill, Fiona O'Driscoll, Lorraine Cremona, Mattia Hennessy, Bryan T Eli, Lisa D Crown, John Collins, Denis M